Jagsonpal Pharmaceuticals
add_icon

Jagsonpal Pharmaceuticals

182.96
-6.65
(-3.51%)
Market Cap
1,221.83 Cr
PE Ratio
31.06
Volume
6,49,002.00
Day High - Low
193.90 - 181.99
52W High-Low
301.65 - 155.00
ann
There are new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,221.83 Cr
EPS
8.26
PE Ratio
31.06
PB Ratio
5.03
Book Value
37.77
EBITDA
59.30
Dividend Yield
1.31 %
Industry
Healthcare
Return on Equity
23.07
Debt to Equity
0.04
Forecast For
Actual

Company News

View All News
Caret
negative
Jagsonpal Pharmaceuticals receives tax demand notice of Rs 4,81,61,360 from Income Tax Department for AY 2024-25 due to disallowed expenses. Company plans to file appeal.
positive
Jagsonpal Pharmaceuticals has scheduled a board meeting for March 12, 2026, to consider and approve a buyback proposal for its fully paid-up equity shares of face value Rs. 2 each under applicable regulations.
positive
Jagsonpal Pharmaceuticals' board committee approved grant of 11,52,500 employee stock options under ESOP 2022 at exercise price of Rs. 139.00 per option, vesting in 4 equal annual tranches.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,801.60
#1 4,32,264.19
39.98
#1 54,729.00
9.71
#1 10,980
16.07
62.14
6,071.00
1,61,165.97
67.21
9,712.00
18.67
2,191
-1.02
38.37
4,390.00
1,48,577.55
66.21
11,539.40
6.99
1,911
26.24
61.73
1,292.30
1,07,859.28
19.93
33,741.20
16.73
5,725
-15.28
51.79
1,314.70
1,06,197.76
23.61
28,409.50
7.12
5,291
-57.18
40.42
2,314.90
1,05,744.36
23.07
22,909.50
13.74
3,306
#1 37.44
57.99
905.90
91,154.74
#1 18.35
23,511.00
18.55
4,615
-0.32
48.43
2,138.90
88,294.88
50.56
12,744.20
#1 20.90
2,007
7.65
47.71
1,296.50
75,300.93
21.89
32,345.60
9.43
3,484
7.59
66.14
5,355.50
64,033.04
26.89
13,458.30
3.70
2,216
1.90
40.57
Growth Rate
Revenue Growth
27.02 %
Net Income Growth
146.22 %
Cash Flow Change
57.24 %
ROE
92.41 %
ROCE
81.03 %
EBITDA Margin (Avg.)
44.20 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
138
144
144
127
168
161
192
221
242
218
277
293
Expenses
129
132
138
138
158
150
169
193
203
186
218
228
EBITDA
9
13
6
-11
11
11
24
29
40
32
59
65
Operating Profit %
6 %
8 %
4 %
-9 %
6 %
5 %
10 %
12 %
14 %
11 %
19 %
19 %
Depreciation
3
3
2
0
1
1
1
2
1
2
8
9
Interest
5
5
3
1
1
1
1
0
0
1
1
1
Profit Before Tax
2
4
14
-12
9
9
22
27
35
30
70
54
Tax
1
1
3
-0
2
2
5
8
8
7
15
12
Net Profit
1
3
12
-12
7
8
17
19
27
23
55
41
EPS in ₹
0.45
1.24
4.53
-4.41
2.75
3.00
6.51
7.20
10.20
8.49
8.26
6.10

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
154
159
143
130
136
147
164
164
195
217
278
Fixed Assets
52
52
22
21
22
22
26
23
24
9
95
Current Assets
96
101
110
95
98
95
121
109
165
199
161
Capital Work in Progress
0
0
0
3
4
4
0
0
0
0
0
Investments
0
0
0
0
0
11
15
51
1
0
0
Other Assets
102
108
121
106
110
109
123
91
170
208
184
Total Equity & Liabilities
154
159
143
130
136
147
164
164
195
217
278
Current Liabilities
55
57
29
29
28
33
40
27
28
19
26
Non Current Liabilities
4
4
3
3
3
3
2
5
9
11
12
Total Equity
95
98
110
98
105
111
122
133
159
187
240
Reserve & Surplus
82
85
97
85
91
98
109
120
146
174
226
Share Capital
13
13
13
13
13
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
2
1
5
-6
24
-1
19
-36
-12
2
-2
Investing Activities
-1
-2
41
-3
-1
-11
-2
-26
-58
-25
-45
Operating Activities
4
9
-3
-2
31
11
28
7
47
35
55
Financing Activities
-1
-6
-34
-1
-6
-1
-7
-18
-1
-9
-12

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
70.34 %
70.34 %
70.34 %
70.34 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.48 %
68.09 %
68.04 %
67.97 %
67.81 %
67.78 %
67.65 %
67.54 %
67.39 %
FIIs
0.00 %
0.00 %
0.11 %
0.20 %
0.00 %
0.00 %
0.13 %
0.00 %
0.00 %
0.00 %
0.38 %
0.00 %
0.73 %
1.10 %
2.30 %
2.10 %
2.10 %
2.18 %
2.12 %
2.12 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.28 %
0.77 %
0.83 %
0.83 %
0.83 %
0.00 %
0.85 %
0.85 %
0.11 %
0.00 %
0.00 %
0.05 %
0.09 %
0.15 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
26.67 %
26.08 %
23.71 %
23.71 %
22.92 %
25.27 %
22.78 %
21.11 %
22.23 %
22.84 %
21.99 %
21.94 %
20.69 %
20.79 %
20.38 %
20.64 %
20.94 %
24.26 %
21.13 %
21.20 %
Others
2.98 %
3.57 %
5.83 %
5.75 %
8.36 %
6.02 %
8.10 %
9.40 %
8.23 %
7.62 %
8.09 %
9.58 %
9.64 %
9.22 %
9.24 %
9.45 %
9.17 %
5.86 %
9.12 %
9.14 %
No of Share Holders
0
12,546
14,655
14,353
20,031
17,100
16,194
14,952
14,084
13,782
16,041
15,785
16,282
15,748
15,633
18,471
21,085
22,899
24,653
24,895

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.1 0.1 0.25 0.5 1 4 5 5 2.5 0.00
Dividend Yield (%) 0.93 0.95 3.56 1.57 0.8 3.45 4.52 2.3 1.37 0.00

Announcements

Announcement Under Regulation 30 Of Sebi LODR1 day ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release2 days ago
Board Meeting Outcome for Outcome Of Board Meeting2 days ago
Board Meeting Intimation for Proposal Of Buyback Of Equity Shares Of The Company5 days ago
Announcement Under Regulation 30 Of SEBI LODR5 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS5 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS5 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 22, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 22, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 21, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 21, 2026
Outcome Of Board Meeting Held On January 21 2026 Along With Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Jan 21, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On January 21 2026 Along With Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Jan 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 15, 2026
Board Meeting Intimation for Intimation Of Board MeetingJan 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 06, 2026
Announcement Under Regulation 30 Of SEBI (LODR) 2015Dec 30, 2025
Closure of Trading WindowDec 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 20, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 03, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 03, 2025
Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Nov 03, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 29, 2025
Board Meeting Intimation for Intimation For Board Meeting.Oct 27, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 07, 2025
Intimation Under Regulation 30 (5) Of The SEBI (LODR) Regulations 2015Oct 07, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementOct 07, 2025
Closure of Trading WindowSep 26, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 26, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 20, 2025
Reg. 34 (1) Annual Report.Sep 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 04, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 04, 2025
Letter To Shareholders For Annual Report Web-Link And PathSep 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2025
Business Responsibility and Sustainability Reporting (BRSR)Sep 01, 2025
Notice Of 46Th Annual General Meeting Of The CompanySep 01, 2025
Reg. 34 (1) Annual Report.Sep 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 08, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.02%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
57.48
ATR(14)
Volatile
9.76
STOCH(9,6)
Neutral
64.47
STOCH RSI(14)
Overbought
91.07
MACD(12,26)
Bullish
1.98
ADX(14)
Weak Trend
20.16
UO(9)
Bearish
48.30
ROC(12)
Uptrend And Accelerating
5.59
WillR(14)
Neutral
-42.18